Main variables;Fields of operation;Total
Units that perform R+D in Biotechnology;Total;1.256
Units that perform R+D in Biotechnology;Units;1.056
Units that perform R+D in Biotechnology;P.A.;123
Units that perform R+D in Biotechnology;Higher Education;66
Units that perform R+D in Biotechnology;PNPI;11
%Units according to biotechnology used: Genetic code;Total;44
%Units according to biotechnology used: Genetic code;Units;36
%Units according to biotechnology used: Genetic code;P.A.;90
%Units according to biotechnology used: Genetic code;Higher Education;86
%Units according to biotechnology used: Genetic code;PNPI;55
%Units according to biotechnology used: Functional units;Total;52
%Units according to biotechnology used: Functional units;Units;45
%Units according to biotechnology used: Functional units;P.A.;90
%Units according to biotechnology used: Functional units;Higher Education;92
%Units according to biotechnology used: Functional units;PNPI;46
%Units according to biotechnology used: Cellular and tissue culturing and engineering;Total;35
%Units according to biotechnology used: Cellular and tissue culturing and engineering;Units;27
%Units according to biotechnology used: Cellular and tissue culturing and engineering;P.A.;76
%Units according to biotechnology used: Cellular and tissue culturing and engineering;Higher Education;80
%Units according to biotechnology used: Cellular and tissue culturing and engineering;PNPI;73
%Units according to biotechnology used: Bioprocesses;Total;50
%Units according to biotechnology used: Bioprocesses;Units;47
%Units according to biotechnology used: Bioprocesses;P.A.;59
%Units according to biotechnology used: Bioprocesses;Higher Education;88
%Units according to biotechnology used: Bioprocesses;PNPI;46
%Units according to biotechnology used: Sub-cellular organisms;Total;17
%Units according to biotechnology used: Sub-cellular organisms;Units;8
%Units according to biotechnology used: Sub-cellular organisms;P.A.;56
%Units according to biotechnology used: Sub-cellular organisms;Higher Education;68
%Units according to biotechnology used: Sub-cellular organisms;PNPI;36
%Units according to biotechnology used: Bio-computing;Total;32
%Units according to biotechnology used: Bio-computing;Units;25
%Units according to biotechnology used: Bio-computing;P.A.;71
%Units according to biotechnology used: Bio-computing;Higher Education;83
%Units according to biotechnology used: Bio-computing;PNPI;27
%Units according to biotechnology used: Nanobiotechnology;Total;20
%Units according to biotechnology used: Nanobiotechnology;Units;13
%Units according to biotechnology used: Nanobiotechnology;P.A.;50
%Units according to biotechnology used: Nanobiotechnology;Higher Education;73
%Units according to biotechnology used: Nanobiotechnology;PNPI;9
%Units according to biotechnology used: Other;Total;14
%Units according to biotechnology used: Other;Units;15
%Units according to biotechnology used: Other;P.A.;9
%Units according to biotechnology used: Other;Higher Education;14
%Units according to biotechnology used: Other;PNPI;9
Units in which biotechnology activities are:  Main and/or exclusive;Total;598
Units in which biotechnology activities are:  Main and/or exclusive;Units;551
Units in which biotechnology activities are:  Main and/or exclusive;P.A.;34
Units in which biotechnology activities are:  Main and/or exclusive;Higher Education;4
Units in which biotechnology activities are:  Main and/or exclusive;PNPI;9
Units in which biotechnology activities are: A secondary line of business;Total;265
Units in which biotechnology activities are: A secondary line of business;Units;183
Units in which biotechnology activities are: A secondary line of business;P.A.;38
Units in which biotechnology activities are: A secondary line of business;Higher Education;43
Units in which biotechnology activities are: A secondary line of business;PNPI;1
Units in which biotechnology activities are: A tool necessary for production;Total;394
Units in which biotechnology activities are: A tool necessary for production;Units;323
Units in which biotechnology activities are: A tool necessary for production;P.A.;51
Units in which biotechnology activities are: A tool necessary for production;Higher Education;19
Units in which biotechnology activities are: A tool necessary for production;PNPI;1
%Units by field(s) of ultimate application of biotechnology use: Human health;Total;54
%Units by field(s) of ultimate application of biotechnology use: Human health;Units;49
%Units by field(s) of ultimate application of biotechnology use: Human health;P.A.;80
%Units by field(s) of ultimate application of biotechnology use: Human health;Higher Education;91
%Units by field(s) of ultimate application of biotechnology use: Human health;PNPI;73
%Units by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Total;22
%Units by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Units;20
%Units by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;P.A.;16
%Units by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Higher Education;62
%Units by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;PNPI;9
%Units by field(s) of ultimate application of biotechnology use: Food products;Total;32
%Units by field(s) of ultimate application of biotechnology use: Food products;Units;30
%Units by field(s) of ultimate application of biotechnology use: Food products;P.A.;20
%Units by field(s) of ultimate application of biotechnology use: Food products;Higher Education;83
%Units by field(s) of ultimate application of biotechnology use: Food products;PNPI;0
%Units by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;Total;25
%Units by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;Units;23
%Units by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;P.A.;19
%Units by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;Higher Education;70
%Units by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;PNPI;18
%Units by field(s) of ultimate application of biotechnology use: Environment;Total;17
%Units by field(s) of ultimate application of biotechnology use: Environment;Units;13
%Units by field(s) of ultimate application of biotechnology use: Environment;P.A.;24
%Units by field(s) of ultimate application of biotechnology use: Environment;Higher Education;71
%Units by field(s) of ultimate application of biotechnology use: Environment;PNPI;9
%Units by field(s) of ultimate application of biotechnology use: Industry;Total;15
%Units by field(s) of ultimate application of biotechnology use: Industry;Units;12
%Units by field(s) of ultimate application of biotechnology use: Industry;P.A.;12
%Units by field(s) of ultimate application of biotechnology use: Industry;Higher Education;68
%Units by field(s) of ultimate application of biotechnology use: Industry;PNPI;9
Personnel in R&D in biotechnology (no. of persons);Total;38.311
Personnel in R&D in biotechnology (no. of persons);Units;10.719
Personnel in R&D in biotechnology (no. of persons);P.A.;13.881
Personnel in R&D in biotechnology (no. of persons);Higher Education;13.355
Personnel in R&D in biotechnology (no. of persons);PNPI;356
Personnel in R&D in biotechnology (no. of persons): Researchers;Total;25.082
Personnel in R&D in biotechnology (no. of persons): Researchers;Units;6.131
Personnel in R&D in biotechnology (no. of persons): Researchers;P.A.;8.130
Personnel in R&D in biotechnology (no. of persons): Researchers;Higher Education;10.534
Personnel in R&D in biotechnology (no. of persons): Researchers;PNPI;287
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Total;13.229
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Units;4.588
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;P.A.;5.751
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Higher Education;2.821
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;PNPI;69
Personnel in R&D in biotechnology (no. of persons): women;Total;21.567
Personnel in R&D in biotechnology (no. of persons): women;Units;6.040
Personnel in R&D in biotechnology (no. of persons): women;P.A.;8.575
Personnel in R&D in biotechnology (no. of persons): women;Higher Education;6.734
Personnel in R&D in biotechnology (no. of persons): women;PNPI;218
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Total;13.264
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Units;3.411
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;P.A.;4.624
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Higher Education;5.057
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;PNPI;172
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Total;8.303
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Units;2.629
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;P.A.;3.951
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Higher Education;1.677
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;PNPI;46
Personnel in R&D in biotechnology (FTE);Total;26.692,1
Personnel in R&D in biotechnology (FTE);Units;7.750,8
Personnel in R&D in biotechnology (FTE);P.A.;10.337,9
Personnel in R&D in biotechnology (FTE);Higher Education;8.497,2
Personnel in R&D in biotechnology (FTE);PNPI;106,2
Personnel in R&D in biotechnology (FTE): Researchers;Total;16.693,3
Personnel in R&D in biotechnology (FTE): Researchers;Units;4.518,1
Personnel in R&D in biotechnology (FTE): Researchers;P.A.;5.616,2
Personnel in R&D in biotechnology (FTE): Researchers;Higher Education;6.496,1
Personnel in R&D in biotechnology (FTE): Researchers;PNPI;62,9
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Total;9.998,8
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Units;3.232,7
Personnel in R&D in biotechnology (FTE): Technicians and assistants;P.A.;4.721,7
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Higher Education;2.001,1
Personnel in R&D in biotechnology (FTE): Technicians and assistants;PNPI;43,3
Personnel in R&D in biotechnology (FTE): women;Total;15.343,5
Personnel in R&D in biotechnology (FTE): women;Units;4.471,4
Personnel in R&D in biotechnology (FTE): women;P.A.;6.461,1
Personnel in R&D in biotechnology (FTE): women;Higher Education;4.337,4
Personnel in R&D in biotechnology (FTE): women;PNPI;73,6
Personnel in R&D in biotechnology (FTE): (women) Researchers;Total;9.002,9
Personnel in R&D in biotechnology (FTE): (women) Researchers;Units;2.562,7
Personnel in R&D in biotechnology (FTE): (women) Researchers;P.A.;3.249,3
Personnel in R&D in biotechnology (FTE): (women) Researchers;Higher Education;3.148
Personnel in R&D in biotechnology (FTE): (women) Researchers;PNPI;42,9
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Total;6.340,6
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Units;1.908,7
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;P.A.;3.211,8
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Higher Education;1.189,4
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;PNPI;30,7
Internal expenditure on R&D (thousands of euros);Total;1.693.773
Internal expenditure on R&D (thousands of euros);Units;679.558
Internal expenditure on R&D (thousands of euros);P.A.;610.723
Internal expenditure on R&D (thousands of euros);Higher Education;397.671
Internal expenditure on R&D (thousands of euros);PNPI;5.821
1) By nature of the expense: Current expenses;Total;1.585.388
1) By nature of the expense: Current expenses;Units;634.631
1) By nature of the expense: Current expenses;P.A.;574.604
1) By nature of the expense: Current expenses;Higher Education;370.428
1) By nature of the expense: Current expenses;PNPI;5.723
1.1) Remuneration to researchers;Total;659.430
1.1) Remuneration to researchers;Units;228.857
1.1) Remuneration to researchers;P.A.;210.344
1.1) Remuneration to researchers;Higher Education;218.729
1.1) Remuneration to researchers;PNPI;1.501
1.2) Remuneration to technicians and assistants;Total;278.456
1.2) Remuneration to technicians and assistants;Units;104.498
1.2) Remuneration to technicians and assistants;P.A.;118.726
1.2) Remuneration to technicians and assistants;Higher Education;54.188
1.2) Remuneration to technicians and assistants;PNPI;1.044
1.3) Other current expenses;Total;647.501
1.3) Other current expenses;Units;301.276
1.3) Other current expenses;P.A.;245.535
1.3) Other current expenses;Higher Education;97.512
1.3) Other current expenses;PNPI;3.178
2) By nature of the expense: Capital expenses;Total;108.386
2) By nature of the expense: Capital expenses;Units;44.927
2) By nature of the expense: Capital expenses;P.A.;36.118
2) By nature of the expense: Capital expenses;Higher Education;27.243
2) By nature of the expense: Capital expenses;PNPI;98
2.1) Land and buildings;Total;13.514
2.1) Land and buildings;Units;2.585
2.1) Land and buildings;P.A.;5.020
2.1) Land and buildings;Higher Education;5.909
2.1) Land and buildings;PNPI;0
2.2) Equipment and instruments;Total;73.707
2.2) Equipment and instruments;Units;23.569
2.2) Equipment and instruments;P.A.;30.028
2.2) Equipment and instruments;Higher Education;20.012
2.2) Equipment and instruments;PNPI;98
2.3) Acquisition of specific R+D software;Total;3.621
2.3) Acquisition of specific R+D software;Units;1.392
2.3) Acquisition of specific R+D software;P.A.;992
2.3) Acquisition of specific R+D software;Higher Education;1.237
2.3) Acquisition of specific R+D software;PNPI;0
2.4) Otros productos de propiedad intelectual específicos para I+D;Total;17.544
2.4) Otros productos de propiedad intelectual específicos para I+D;Units;17.381
2.4) Otros productos de propiedad intelectual específicos para I+D;P.A.;78
2.4) Otros productos de propiedad intelectual específicos para I+D;Higher Education;85
2.4) Otros productos de propiedad intelectual específicos para I+D;PNPI;0
1) By origin of the funds: National funds;Total;1.456.745
1) By origin of the funds: National funds;Units;556.297
1) By origin of the funds: National funds;P.A.;546.727
1) By origin of the funds: National funds;Higher Education;348.357
1) By origin of the funds: National funds;PNPI;5.365
1.1) Own funds;Total;597.793
1.1) Own funds;Units;387.010
1.1) Own funds;P.A.;135.388
1.1) Own funds;Higher Education;74.853
1.1) Own funds;PNPI;541
1.2) From companies;Total;171.566
1.2) From companies;Units;86.025
1.2) From companies;P.A.;50.625
1.2) From companies;Higher Education;32.844
1.2) From companies;PNPI;2.073
1.3) Public Administration funds;Total;638.127
1.3) Public Administration funds;Units;74.764
1.3) Public Administration funds;P.A.;329.591
1.3) Public Administration funds;Higher Education;232.956
1.3) Public Administration funds;PNPI;816
1.4) From Universities;Total;2.780
1.4) From Universities;Units;408
1.4) From Universities;P.A.;1.808
1.4) From Universities;Higher Education;535
1.4) From Universities;PNPI;29
1.5) From non profit private institutions;Total;46.480
1.5) From non profit private institutions;Units;8.090
1.5) From non profit private institutions;P.A.;29.315
1.5) From non profit private institutions;Higher Education;7.170
1.5) From non profit private institutions;PNPI;1.906
1) By origin of the funds: Foreign funds;Total;237.028
1) By origin of the funds: Foreign funds;Units;123.262
1) By origin of the funds: Foreign funds;P.A.;63.996
1) By origin of the funds: Foreign funds;Higher Education;49.314
1) By origin of the funds: Foreign funds;PNPI;456
2.1) From EU programmes;Total;119.838
2.1) From EU programmes;Units;25.125
2.1) From EU programmes;P.A.;52.212
2.1) From EU programmes;Higher Education;42.501
2.1) From EU programmes;PNPI;0
2.2) Other foreign funds;Total;117.190
2.2) Other foreign funds;Units;98.137
2.2) Other foreign funds;P.A.;11.784
2.2) Other foreign funds;Higher Education;6.813
2.2) Other foreign funds;PNPI;456
Purchase of services R & D in Biotechnology to (thousands of euros);Total;177.895
Purchase of services R & D in Biotechnology to (thousands of euros);Units;147.558
Purchase of services R & D in Biotechnology to (thousands of euros);P.A.;26.353
Purchase of services R & D in Biotechnology to (thousands of euros);Higher Education;3.597
Purchase of services R & D in Biotechnology to (thousands of euros);PNPI;386
Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;Total;105.337
Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;Units;76.875
Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;P.A.;24.581
Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;Higher Education;3.554
Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;PNPI;326
Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;Total;72.558
Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;Units;70.683
Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;P.A.;1.772
Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;Higher Education;43
Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;PNPI;60
%Units that consider the following obstacles as very important considering biotechnology development: Access to capital;Total;50
%Units that consider the following obstacles as very important considering biotechnology development: Access to capital;Units;49
%Units that consider the following obstacles as very important considering biotechnology development: Access to capital;P.A.;58
%Units that consider the following obstacles as very important considering biotechnology development: Access to capital;Higher Education;53
%Units that consider the following obstacles as very important considering biotechnology development: Access to capital;PNPI;73
%Units that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Total;13
%Units that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Units;14
%Units that consider the following obstacles as very important considering biotechnology development: Access to technology / information;P.A.;7
%Units that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Higher Education;8
%Units that consider the following obstacles as very important considering biotechnology development: Access to technology / information;PNPI;27
%Units that consider the following obstacles as very important considering biotechnology development: Access to human resources;Total;20
%Units that consider the following obstacles as very important considering biotechnology development: Access to human resources;Units;16
%Units that consider the following obstacles as very important considering biotechnology development: Access to human resources;P.A.;42
%Units that consider the following obstacles as very important considering biotechnology development: Access to human resources;Higher Education;41
%Units that consider the following obstacles as very important considering biotechnology development: Access to human resources;PNPI;27
%Units that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Total;15
%Units that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Units;13
%Units that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;P.A.;27
%Units that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Higher Education;30
%Units that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;PNPI;18
%Units that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;Total;20
%Units that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;Units;18
%Units that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;P.A.;33
%Units that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;Higher Education;36
%Units that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;PNPI;18
%Units that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;Total;20
%Units that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;Units;18
%Units that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;P.A.;29
%Units that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;Higher Education;36
%Units that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;PNPI;36
%Units that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;Total;16
%Units that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;Units;17
%Units that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;P.A.;9
%Units that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;Higher Education;11
%Units that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;PNPI;18
%Units that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Total;37
%Units that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Units;37
%Units that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;P.A.;39
%Units that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Higher Education;30
%Units that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;PNPI;46
%Units that consider the following obstacles as very important considering biotechnology development: Time / cost;Total;52
%Units that consider the following obstacles as very important considering biotechnology development: Time / cost;Units;51
%Units that consider the following obstacles as very important considering biotechnology development: Time / cost;P.A.;54
%Units that consider the following obstacles as very important considering biotechnology development: Time / cost;Higher Education;58
%Units that consider the following obstacles as very important considering biotechnology development: Time / cost;PNPI;55
%Units that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Total;18
%Units that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Units;18
%Units that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;P.A.;20
%Units that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Higher Education;14
%Units that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;PNPI;27
%Units that have requested biotechnology patents in Biotechnology;Total;21
%Units that have requested biotechnology patents in Biotechnology;Units;15
%Units that have requested biotechnology patents in Biotechnology;P.A.;43
%Units that have requested biotechnology patents in Biotechnology;Higher Education;74
%Units that have requested biotechnology patents in Biotechnology;PNPI;0
Number of patents requested;Total;1.770
Number of patents requested;Units;746
Number of patents requested;P.A.;539
Number of patents requested;Higher Education;485
Number of patents requested;PNPI;0